Cooper Gross Margin 2010-2024 | COO

Current and historical gross margin for Cooper (COO) over the last 10 years. The current gross profit margin for Cooper as of January 31, 2024 is %.
Cooper Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-01-31 $3.67B $2.42B 66.09%
2023-10-31 $3.59B $2.36B 65.63%
2023-07-31 $3.51B $2.29B 65.14%
2023-04-30 $3.43B $2.23B 65.10%
2023-01-31 $3.38B $2.18B 64.53%
2022-10-31 $3.31B $2.14B 64.69%
2022-07-31 $3.22B $2.11B 65.39%
2022-04-30 $3.14B $2.07B 65.91%
2022-01-31 $3.03B $2.02B 66.79%
2021-10-31 $2.92B $1.96B 66.92%
2021-07-31 $2.85B $1.88B 65.99%
2021-04-30 $2.66B $1.72B 64.75%
2021-01-31 $2.47B $1.56B 63.26%
2020-10-31 $2.43B $1.54B 63.18%
2020-07-31 $2.44B $1.57B 64.20%
2020-04-30 $2.54B $1.66B 65.18%
2020-01-31 $2.67B $1.77B 66.12%
2019-10-31 $2.65B $1.76B 66.26%
2019-07-31 $2.61B $1.73B 66.32%
2019-04-30 $2.59B $1.71B 65.88%
2019-01-31 $2.57B $1.68B 65.38%
2018-10-31 $2.53B $1.63B 64.47%
2018-07-31 $2.44B $1.56B 63.69%
2018-04-30 $2.34B $1.49B 63.49%
2018-01-31 $2.23B $1.42B 63.86%
2017-10-31 $2.14B $1.37B 63.81%
2017-07-31 $2.10B $1.31B 62.40%
2017-04-30 $2.06B $1.27B 61.75%
2017-01-31 $2.02B $1.22B 60.68%
2016-10-31 $1.97B $1.17B 59.65%
2016-07-31 $1.91B $1.13B 59.37%
2016-04-30 $1.85B $1.09B 58.69%
2016-01-31 $1.80B $1.06B 58.57%
2015-10-31 $1.80B $1.07B 59.51%
2015-07-31 $1.81B $1.10B 60.61%
2015-04-30 $1.78B $1.11B 62.08%
2015-01-31 $1.76B $1.11B 62.89%
2014-10-31 $1.72B $1.09B 63.60%
2014-07-31 $1.66B $1.08B 64.78%
2014-04-30 $1.64B $1.06B 64.78%
2014-01-31 $1.61B $1.05B 65.03%
2013-10-31 $1.59B $1.03B 64.61%
2013-07-31 $1.57B $1.02B 64.57%
2013-04-30 $1.54B $0.99B 64.17%
2013-01-31 $1.50B $0.95B 63.64%
2012-10-31 $1.45B $0.92B 63.94%
2012-07-31 $1.41B $0.90B 63.48%
2012-04-30 $1.38B $0.86B 62.04%
2012-01-31 $1.36B $0.84B 61.56%
2011-10-31 $1.33B $0.81B 60.60%
2011-07-31 $1.28B $0.77B 59.98%
2011-04-30 $1.23B $0.74B 60.47%
2011-01-31 $1.19B $0.70B 59.03%
2010-10-31 $1.16B $0.68B 58.38%
2010-07-31 $1.13B $0.65B 57.45%
2010-04-30 $1.12B $0.62B 55.33%
2010-01-31 $1.09B $0.60B 55.46%
2009-10-31 $1.08B $0.60B 55.19%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.860B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.42
Align Technology (ALGN) United States $19.244B 37.15
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00